Topic prioritisation
Showing 1 to 1 of 1
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331] | None selected | Awaiting decision |
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331] | None selected | Awaiting decision |